Effects of Inhaled Iloprost on Exercise Capacity, Quality of Life, and Cardiac Function in Patients With Pulmonary Arterial Hypertension Secondary to Congenital Heart Disease (the Eisenmenger Syndrome) (from the EIGER Study)-Reference-Cited by-同舟云学术

Effects of Inhaled Iloprost on Exercise Capacity, Quality of Life, and Cardiac Function in Patients With Pulmonary Arterial Hypertension Secondary to Congenital Heart Disease (the Eisenmenger Syndrome) (from the EIGER Study)

Published:2013-12 Issue:11 Volume:112 Page:1834-1839
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Cha Kwang Soo,Cho Kyoung Im,Seo Jeong Sook,Choi Jung Hyun,Park Yong Hyun,Yang Dong Heon,Hong Geu Ru,Kim Dong Soo

Funder

Pharmaceuticals Bayer

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Evidence-based pharmacologic management of pulmonary arterial hypertension;Benedict;Clin Ther,2007

2. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study;Galie;Circulation,2006

3. Use of the 12-item short-form (SF-12) health survey in an Australian heart and stroke population;Lim;Qual Life Res,1999

4. Development of the Korean version of Short-Form 36-Item Health Survey: health-related QOL of healthy elderly people and elderly patients in Korea;Han;Tohoku J Exp Med,2004

5. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment;Gandek;J Clin Epidemiol,1998

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on Eisenmenger syndrome – Review of pathophysiology and recent progress in risk assessment and management;International Journal of Cardiology Congenital Heart Disease;2024-09

2. Efficacy and safety of iloprost in the treatment of pulmonary arterial hypertension: A systematic review and meta-analysis;Heart & Lung;2024-03

3. Pulmonary Hypertension in Adults with Congenital Heart Disease;Pediatric Cardiology;2024

4. “Adults with congenital heart defects”: current challenges in medical care. Part II: infective endocarditis, pulmonary hypertension, aortopathy, cardiac surgical aspects, psychocardiology, unresolved problems and future aspects;Die Kardiologie;2023-07-06

5. Cardiac Drugs in ACHD Cardiovascular Medicine;Journal of Cardiovascular Development and Disease;2023-04-24